Monitoring the safe and effective use of medicines has now been an essential part of public health policy for several decades. New advances in technology (e.g., ICH E2B for the electronic exchange of case reports) over the past 20 years coupled with progressive legislation have been a catalyst for an explosion in safety data over this period.
Since the World Health Organization (WHO) declared the Covid-19 pandemic in March 2020, the rate of reporting of safety data has been unprecedented
Read More
big data
Philips’ Future Health Index 2022 Report: 4 Key Trends to Know
What You Should Know:
- Today, Philips announced the publication of its Future Health Index (FHI) 2022 report: ‘Healthcare hits reset: Priorities shift as healthcare leaders navigate a changed world’. FHI is the largest global survey of its kind, analyzing feedback from nearly 3,000 healthcare leaders across 15 countries on the impact of digital health technology in the adoption of connected care.
- This year’s FHI report, the seventh edition, looks at how
Read More
Axuall’s CEO Talks Why Health Administrators Should Adopt Robotic Process Automation
Axuall’s CEO & Founder, Charlie Lougheed shares why health administration teams should embrace the power of robotic process automation (RPA).
Built with leading healthcare systems, Axuall is a workforce intelligence company powered by a national real-time practitioner data network. The technology enables healthcare systems, staffing firms, telehealth, and health plans to dramatically reduce onboarding and enrollment time while also providing unique, powerful data insights for network
Read More
Clarify Health Secures $150M for Value-Based Payments Platform
What You Should Know:
- Clarify Health, a cloud analytics and value-based payments platform company, announced today that it secured $150 million in Series D financing. SoftBank Vision Fund 2 led the round and was joined by funds and accounts managed by BlackRock and Memorial Hermann Health System, along with existing investors Insight Partners, Spark Capital, KKR, Aspenwood Ventures, Rivas Capital, and Sigmas Group.
- This newest round of funding comes on the heels of the
Read More
Why Mainstream Precision Medicine Hinges on Healthcare HPC Storage
The healthcare industry is experiencing a data deluge, and it shows no sign of slowing down.
In 2020, estimates reported that healthcare data comprised a staggering 30% of the world’s total data volume; projections for 2025 bump that number up to 36%, a growth rate outpacing every other industry.
This is promising news for precision medicine, the data-driven healthcare initiative that promotes the right treatment for the right patient at the right time.
Precision (or personalized)
Read More
Foresite Capital Raises $173M Fund for Foresite Labs Incubated Companies
What You Should Know:
- Foresite Capital is announcing their latest, oversubscribed $173M fund, which will be used to support Foresite Labs’ incubated life science companies.
- Foresite Labs was created in October 2019 to found, build, and scale life sciences companies at the intersection of healthcare and data science. One of Foresite Capital’s core beliefs is that by combining machine learning, big data, and genomics, life sciences companies can accelerate commercialization from decades
Read More
Definitive Healthcare Acquires Analytical Wizards, Healthcare Analytics Platform
What You Should Know:
- This week, Definite Healthcare announced the acquisition of Analytical Wizards, an advanced analytics company revolutionizing analytics in healthcare by combining our AI/ML-powered technology, domain expertise, and high-touch relationship model. Financial details of the acquisition were not disclosed.
- Founded in 2015, Analytical Wizards automates complex analytic models using tools that expedite efficient big data mining using artificial intelligence (AI) and
Read More
Helping Clinical Trial Sites Improve Study Recruitment and Retention
The clinical trial industry is, once again, at an uncertain crossroads. And while it might be assumed that the outsized impact of the COVID-19 pandemic has resulted in the inability to recruit patients for trials, it is instead, a challenge generated, over time, by the industry itself. Thankfully, there is an opportunity to change course.
It’s no secret that research studies and clinical trial sites struggle with recruitment. In fact, the National Institutes of Health (NIH) states
Read More
COVID Exposed The Dire Need for Real-Time Healthcare Data Sharing
In a world where technology and Big Data can provide us with instantaneous access to our banking transactions, and our financial information and credit reports can be retrieved with a few keystrokes when applying for a mortgage -- trying to get access to our own healthcare data is exasperating. Beyond exasperating, is the frightening situation when the inability to access up-to-date and accurate information, can result in an aggravated medical condition or even death.
Before the
Read More
To Advance Health Equity, Put Real-World Cancer Data to Work
Despite decades of scientific progress against cancer, access to treatment remains highly unequal. Some of the reasons — like institutional racism and poverty — are a reflection of our broader society. Other inequities may go unrecognized but are no less damaging. People with underlying health conditions, for example, may be excluded from clinical trials, preventing them from accessing leading-edge treatments and limiting the evidence available to guide their care.
With multiple drivers of
Read More
